These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20637812)

  • 21. The pH Stability of Foot-and-Mouth Disease Virus Particles Is Modulated by Residues Located at the Pentameric Interface and in the N Terminus of VP1.
    Caridi F; Vázquez-Calvo A; Sobrino F; Martín-Acebes MA
    J Virol; 2015 May; 89(10):5633-42. PubMed ID: 25762735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering Responses to Amino Acid Substitutions in the VP0- and VP3-Coding Regions of PanAsia-1 Strains of Foot-and-Mouth Disease Virus Serotype O.
    Bai XW; Bao HF; Li PH; Ma XQ; Sun P; Bai QF; Zhang M; Yuan H; Chen DD; Li K; Chen YL; Cao YM; Fu YF; Zhang J; Li D; Lu ZJ; Liu ZX; Luo JX
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30700601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro and in-vivo phenotype of type Asia 1 foot-and-mouth disease viruses utilizing two non-RGD receptor recognition sites.
    Li P; Lu Z; Bao H; Li D; King DP; Sun P; Bai X; Cao W; Gubbins S; Chen Y; Xie B; Guo J; Yin H; Liu Z
    BMC Microbiol; 2011 Jun; 11():154. PubMed ID: 21711567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1.
    Zaini Z; Phuektes P; McMinn P
    Virus Res; 2012 Jul; 167(1):86-96. PubMed ID: 22575826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic site variation in foot-and-mouth disease virus serotype O grown under vaccinal serum antibodies in vitro.
    Sarangi LN; Mohapatra JK; Subramaniam S; Sanyal A; Pattnaik B
    Virus Res; 2013 Sep; 176(1-2):273-9. PubMed ID: 23850868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
    Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
    Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a novel cell culture adaptation site on the capsid of foot-and-mouth disease virus.
    Chamberlain K; Fowler VL; Barnett PV; Gold S; Wadsworth J; Knowles NJ; Jackson T
    J Gen Virol; 2015 Sep; 96(9):2684-2692. PubMed ID: 26296881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection and characterization of an acid-resistant mutant of serotype O foot-and-mouth disease virus.
    Liang T; Yang D; Liu M; Sun C; Wang F; Wang J; Wang H; Song S; Zhou G; Yu L
    Arch Virol; 2014 Apr; 159(4):657-67. PubMed ID: 24122111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice.
    Chen W; Yan W; Du Q; Fei L; Liu M; Ni Z; Sheng Z; Zheng Z
    J Virol; 2004 Jul; 78(13):6900-7. PubMed ID: 15194766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombination of host cell mRNA with the Asia 1 foot-and-mouth disease virus genome in cell suspension culture.
    Zou X; Zhu Y; Bao H; Guo X; Sun P; Liu Z; Mason PW; Xu L; Li C; Zhang Q; Wang Q; Zhu H; Zhao Q
    Arch Virol; 2019 Jan; 164(1):41-50. PubMed ID: 30232612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.
    Baranowski E; Ruiz-Jarabo CM; Sevilla N; Andreu D; Beck E; Domingo E
    J Virol; 2000 Feb; 74(4):1641-7. PubMed ID: 10644333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of foot-and-mouth disease virus integrin receptor expression in tissues from naïve and infected cattle.
    O'Donnell V; Pacheco JM; Gregg D; Baxt B
    J Comp Pathol; 2009; 141(2-3):98-112. PubMed ID: 19515380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic characterization of type A foot-and-mouth disease virus 3A region in context of the reemergence of VP359-deletion lineage in India.
    Mohapatra JK; Sahu A; Pandey L; Sanyal A; Hemadri D; Pattnaik B
    Infect Genet Evol; 2009 Jul; 9(4):483-92. PubMed ID: 19460313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of foot-and-mouth disease virus internalization events in cultured cells.
    O'Donnell V; LaRocco M; Duque H; Baxt B
    J Virol; 2005 Jul; 79(13):8506-18. PubMed ID: 15956593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and antigenic analysis of two recently circulating genotypes of type A foot-and-mouth disease virus in India: evidence for positive selection in the capsid-coding genes.
    Tosh C; Hemadri D; Sanyal A; Bandyopadhyay SK
    Arch Virol; 2003 May; 148(5):853-69. PubMed ID: 12721795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and antigenic site analysis of foot-and-mouth disease virus from pigs and cattle in Korea.
    Oem JK; Lee KN; Cho IS; Kye SJ; Park JY; Park JH; Kim YJ; Joo YS; Song HJ
    J Vet Sci; 2005 Jun; 6(2):117-24. PubMed ID: 15933431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering viable foot-and-mouth disease viruses with increased acid stability facilitate the development of improved vaccines.
    Yuan H; Li P; Bao H; Sun P; Bai X; Bai Q; Li N; Ma X; Cao Y; Fu Y; Li K; Zhang J; Li D; Chen Y; Zhang J; Lu Z; Liu Z
    Appl Microbiol Biotechnol; 2020 Feb; 104(4):1683-1694. PubMed ID: 31900553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational flexibility in a highly mobile protein loop of foot-and-mouth disease virus: distinct structural requirements for integrin and antibody binding.
    Feliu JX; Benito A; Oliva B; Avilés FX; Villaverde A
    J Mol Biol; 1998 Oct; 283(2):331-8. PubMed ID: 9769208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs.
    Zhang Q; Yang YQ; Zhang ZY; Li L; Yan WY; Jiang WJ; Xin AG; Lei CX; Zheng ZX
    Acta Virol; 2002; 46(1):1-9. PubMed ID: 12199204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prokaryotic expression, protein purification and reactivity analysis of the VP1 and its C terminus of a South African isolate of FMDV serotype SAT2].
    Gao SD; Chang HY; Du JZ; Shao JJ; Cong GZ; Lin T; Han XQ; Xie QG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):631-4. PubMed ID: 20619084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.